[
  {
    "ts": null,
    "headline": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q2 2025 Update",
    "summary": "Discover AQR Capital's latest Q2 2025 portfolio movesâtop holdings, stake increases, and insights on their quantitative investment strategy.",
    "url": "https://finnhub.io/api/news?id=19b42167fd2d6deff26ad7bae002671774d41c2c5187d1c5197b982106447492",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758490501,
      "headline": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q2 2025 Update",
      "id": 136838830,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Discover AQR Capital's latest Q2 2025 portfolio movesâtop holdings, stake increases, and insights on their quantitative investment strategy.",
      "url": "https://finnhub.io/api/news?id=19b42167fd2d6deff26ad7bae002671774d41c2c5187d1c5197b982106447492"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks",
    "summary": "Kenvue Inc. (NYSE:KVUE) is included among the 10 Best NYSE Dividend Stocks to Buy. Kenvue Inc. (NYSE:KVUE) produces and sells consumer health products across several categories, including over-the-counter medicines, personal care, and wellness items. Its portfolio features well-known household brands such as Tylenol for pain and fever relief, Neutrogena for skin care, and Listerine for oral […]",
    "url": "https://finnhub.io/api/news?id=4bfebb4a85ec2e5f21e4d315fcdfd96e11395520a9c59c5d24bb3bfcc4d975dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758470659,
      "headline": "Kenvue’s (KVUE) Long-Term Value Creation and its Place in NYSE Dividend Stocks",
      "id": 136836534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Kenvue Inc. (NYSE:KVUE) is included among the 10 Best NYSE Dividend Stocks to Buy. Kenvue Inc. (NYSE:KVUE) produces and sells consumer health products across several categories, including over-the-counter medicines, personal care, and wellness items. Its portfolio features well-known household brands such as Tylenol for pain and fever relief, Neutrogena for skin care, and Listerine for oral […]",
      "url": "https://finnhub.io/api/news?id=4bfebb4a85ec2e5f21e4d315fcdfd96e11395520a9c59c5d24bb3bfcc4d975dd"
    }
  },
  {
    "ts": null,
    "headline": "Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?",
    "summary": "The trillion-dollar club will probably need to make room for at least one Dividend King in the coming years.",
    "url": "https://finnhub.io/api/news?id=92df54fc0dcf25d8b15389930371dd5eff04bfb5587ca807440dfbf887117883",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758447840,
      "headline": "Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?",
      "id": 136836524,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The trillion-dollar club will probably need to make room for at least one Dividend King in the coming years.",
      "url": "https://finnhub.io/api/news?id=92df54fc0dcf25d8b15389930371dd5eff04bfb5587ca807440dfbf887117883"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s (JNJ) Dividend Growth Record Strengthens its Role in Dividend Paying Stocks",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dividend Paying Stocks to Buy Now. Johnson & Johnson (NYSE:JNJ) is a major player in the pharmaceutical and medical device industries, with a recent market value close to $425 billion. The company is also showing growth, as second-quarter revenue increased 5.8% from the previous year […]",
    "url": "https://finnhub.io/api/news?id=39c1d4f534f825ed0d46c8f5582eaf9c7f7b4aaef9752d52b54dba9cc958bdb6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758428707,
      "headline": "Johnson & Johnson’s (JNJ) Dividend Growth Record Strengthens its Role in Dividend Paying Stocks",
      "id": 136836536,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dividend Paying Stocks to Buy Now. Johnson & Johnson (NYSE:JNJ) is a major player in the pharmaceutical and medical device industries, with a recent market value close to $425 billion. The company is also showing growth, as second-quarter revenue increased 5.8% from the previous year […]",
      "url": "https://finnhub.io/api/news?id=39c1d4f534f825ed0d46c8f5582eaf9c7f7b4aaef9752d52b54dba9cc958bdb6"
    }
  }
]